Message :
Required fields The Elecsys(R) SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection Roche will be able to ramp up to a double-digit million number of tests per month, by early 2021 The test is the latest addition to Roches comprehensive COVID-19 portfolio and can help in the management of patients for optimal care delivery Basel, 11 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced
today that it has launched a high-throughput SARS-CoV-2 antigen test as
an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus